Free Trial

Willow Biosciences (WLLW) Competitors

Willow Biosciences logo
C$0.09
0.00 (0.00%)
(As of 11/1/2024 ET)

WLLW vs. VIR, ZOM, IN, META, CWEB, LABS, DB, NRTH, MRV, and CTX

Should you be buying Willow Biosciences stock or one of its competitors? The main competitors of Willow Biosciences include Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), Meta Growth (META), Charlotte's Web (CWEB), MediPharm Labs (LABS), Decibel Cannabis (DB), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), and Crescita Therapeutics (CTX). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Willow Biosciences vs.

Willow Biosciences (TSE:WLLW) and Viridium Pacific Group (CVE:VIR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, community ranking, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

In the previous week, Viridium Pacific Group had 1 more articles in the media than Willow Biosciences. MarketBeat recorded 1 mentions for Viridium Pacific Group and 0 mentions for Willow Biosciences. Willow Biosciences' average media sentiment score of 0.00 equaled Viridium Pacific Group'saverage media sentiment score.

Company Overall Sentiment
Willow Biosciences Neutral
Viridium Pacific Group Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Willow Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Viridium Pacific Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

0.1% of Willow Biosciences shares are held by institutional investors. 24.3% of Willow Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Willow Biosciences has higher revenue and earnings than Viridium Pacific Group. Viridium Pacific Group is trading at a lower price-to-earnings ratio than Willow Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Willow BiosciencesC$1.84M7.05-C$8.70M-C$0.06-1.50
Viridium Pacific GroupC$1.09M34.46-C$12.64M-C$0.13-2.97

Viridium Pacific Group received 26 more outperform votes than Willow Biosciences when rated by MarketBeat users. Likewise, 83.33% of users gave Viridium Pacific Group an outperform vote while only 82.35% of users gave Willow Biosciences an outperform vote.

CompanyUnderperformOutperform
Willow BiosciencesOutperform Votes
14
82.35%
Underperform Votes
3
17.65%
Viridium Pacific GroupOutperform Votes
40
83.33%
Underperform Votes
8
16.67%

Viridium Pacific Group's return on equity of 0.00% beat Willow Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Willow BiosciencesN/A -212.20% -74.79%
Viridium Pacific Group N/A N/A N/A

Summary

Willow Biosciences and Viridium Pacific Group tied by winning 6 of the 12 factors compared between the two stocks.

Get Willow Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for WLLW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WLLW vs. The Competition

MetricWillow BiosciencesDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$12.98MC$1.22BC$5.40BC$5.94B
Dividend Yield7.35%3.13%5.15%5.37%
P/E Ratio-1.50110.73112.5525.87
Price / Sales7.053,426.271,478.821,515.70
Price / Cash0.8310.1939.8381.06
Price / BookN/A3.174.643.11
Net Income-C$8.70MC$155.16MC$119.13MC$292.76M
7 Day PerformanceN/A-0.07%0.78%-1.65%
1 Month PerformanceN/A-0.75%5.65%2.32%
1 Year PerformanceN/A100.86%36.90%45.73%

Willow Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WLLW
Willow Biosciences
N/AC$0.09
flat
N/A+12.5%C$12.98MC$1.84M-1.5019Gap Up
VIR
Viridium Pacific Group
N/AC$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
N/AC$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6150Gap Down
IN
InMed Pharmaceuticals
N/AN/AN/AN/AC$33.73MC$574,677.00-2.7712
META
Meta Growth
N/AC$0.14
flat
N/A+0.0%C$33.14MC$60.96M-0.6686,500News Coverage
Gap Down
CWEB
Charlotte's Web
N/AC$0.20
-4.9%
N/A-41.2%C$30.71MC$54.55M-0.49164Gap Down
LABS
MediPharm Labs
N/AC$0.07
flat
N/A+0.0%C$28.78MC$37.76M-1.75130Gap Up
DB
Decibel Cannabis
1.5546 of 5 stars
C$0.07
-7.1%
C$0.28
+335.9%
-48.1%C$26.59MC$105.60M-6.5083,000Analyst Revision
News Coverage
Gap Down
High Trading Volume
NRTH
48North Cannabis
N/AC$0.07
-6.7%
N/A+0.0%C$15.76MC$18.90M-0.3047
MRV
Nuvo Pharmaceuticals
N/AN/AN/AN/AC$15.38MC$72.42M-19.29N/A
CTX
Crescita Therapeutics
N/AC$0.59
flat
N/A-3.3%C$11.43MC$16.84M-3.9362News Coverage
High Trading Volume

Related Companies and Tools


This page (TSE:WLLW) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners